CTRI/2019/11/021896尚未招募3 期
Milrinone for the treatment of persistent pulmonary hypertension in term and late preterm infants - a pilot randomized controlled trial. - NeoMPH trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Infants of all gender with Gestational age >34 weeks and birth weight >=1800g
- •2. <14 days of age
- •3.Echocardiographic diagnosis of PPHN
- •4.Requirement for mechanical ventilation
排除标准
- •1.Major congenital anomalies or syndromes including congenital diaphragmatic hernia
- •2.Any congenital heart disease
- •3.Clinically evident bleeding diathesis or platelet count <50,000/cmm
- •4.Hypotension refractory to usual medical treatment (>=20 mL/kg fluid bolus and >=2 inotropes)
研究者
相似试验
进行中(未招募)
1 期
sing Milrinone in babies with high blood pressure in the lungs soon after birthMedDRA version: 22.0Level: PTClassification code 10053592Term: Newborn persistent pulmonary hypertensionSystem Organ Class: 10010331 - Congenital, familial and genetic disordersPersistent Pulmonary Hypertension of the NewbornEUCTR2014-002988-16-NLRoyal College of Surgeons in Ireland20
撤回
不适用
The Use of Milrinone in Neonates with Persistent Pulmonary Hypertension of the Newborn: A Randomised Controlled Trial Pilot StudyPersisterende pulmonale hypertensie van de pasgeborenePersistent pulmonary hypertension of the neonate1001928010028971NL-OMON48755RCSI Clinical Research Centre, Royal College of Surgeons in Ireland15
进行中(未招募)
1 期
sing Milrinone in babies with high blood pressure in the lungs soon after birthPersistent Pulmonary Hypertension of the NewbornMedDRA version: 19.1Level: LLTClassification code 10053592Term: Newborn persistent pulmonary hypertensionSystem Organ Class: 100000004850EUCTR2014-002988-16-IERoyal College of Surgeons in Ireland30
进行中(未招募)
1 期
CLINICAL TRIAL TO EVALUATE THE EFFICIENCY OF PYRPHENIDONE FOR THE REDUCTION OF PULMONARY INFLAMMATION IN PATIENTS WITH SILICOSIS AND PROGRESSIVE MASSIVE FIBROSIS.progressive massive fibrosisMedDRA version: 20.0Level: PTClassification code 10040678Term: SilicosisSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 21.1Level: PTClassification code 10036805Term: Progressive massive fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2021-002701-94-ESFundación para la Gestión de la Investigación Biomédica de Cádiz18
招募中
1 期
Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi Decoction based on the Fuzheng Quxie Classical Prescription: a multicenter, randomized, controlled clinical trialHospital-acquired pneumonia with multi-drug resistant organismITMCTR1900002274ongHua Hospital Shanghai University of Traditional Chinese Medicine
